Introduction: Opioid overdose rescue situations are time-critical, high-stress scenarios that frequently require nonmedical first responders or bystanders to intervene and administer naloxone to avoid opioid-induced fatalities. Training nonmedical personnel to respond during such mentally constraining situations presents the human factors challenge of how best to design a safe and effective lay delivery system. This paper comparatively evaluates the ease of use of two nasal naloxone administration products: NARCAN Nasal Spray and a naloxone prefilled syringe with nasal atomizer (PFS-NA).

Methods: We evaluated the use requirements and usability of NARCAN Nasal Spray versus a naloxone PFS-NA using a systems-oriented method. First, we determined the use requirements of different user groups. Next, we focused on constructing a human factors task analysis of both products. Finally, we conducted a comparative risk assessment of the tasks that were different between the two products.

Results: Inexperienced users, such as nonmedical first responders and bystanders, are at the highest risk of incorrectly administering naloxone, particularly in high-stress emergency opioid overdose situations. The device Preparation and Medication Delivery tasks most differentiate the use of NARCAN Nasal Spray and a PFS-NA. The level of task complexity and number of steps within those tasks is substantially greater for a PFS-NA than for the NARCAN Nasal Spray.

Conclusions: NARCAN Nasal Spray requires fewer steps and is easier to administer than a naloxone PFS-NA. Thus, using NARCAN Nasal Spray should increase the likelihood that nonmedical personnel correctly deliver naloxone in time-critical, high-stress opioid overdose rescue situations.

Funding: ADAPT Pharma, Inc.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513948PMC
http://dx.doi.org/10.1007/s40122-019-0118-0DOI Listing

Publication Analysis

Top Keywords

narcan nasal
28
nasal spray
24
human factors
12
opioid overdose
12
nasal
11
naloxone
9
nasal naloxone
8
naloxone administration
8
spray naloxone
8
naloxone prefilled
8

Similar Publications

Insurance coverage and consistent pricing is needed for over-the-counter naloxone.

J Opioid Manag

January 2025

Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill; South East Area Health Education Center, College of Nursing, University of North Carolina Wilmington, Wilmington, North Carolina. ORCID: https://orcid.org/0000-0002-7507-0631.

With the Food and Drug Administration's approval of the first over-the-counter naloxone nasal spray in 2023, it was expected that access to naloxone nasal spray would increase and that its cost would be reduced. However, the writers of this commentary found varying insurance coverage of naloxone during purchase attempts at local pharmacies. Failure to cover naloxone can reduce access and increase risk of overdose death.

View Article and Find Full Text PDF

A call for compassionate opioid overdose response.

Int J Drug Policy

November 2024

T. Stephen Jones Public Health Consulting, 123 Black Birch Trail, Florence MA 01062, USA. Electronic address:

High dose and long-acting opioid overdose reversal drugs can precipitate withdrawal in people who are opioid dependent. Products recently brought to market for community use in the United States (US) have drawn international concern because of their increased risk of withdrawal. At the March 18-19, 2024, Compassionate Overdose Response Summit & Naloxone Dosing Meeting, a panel of harm reduction experts issued the following call to action: 1) people who use drugs should be directly involved in decisions regarding the research, development, selection, and distribution of opioid overdose reversal products; 2) regulatory agencies and pharmaceutical manufacturers should carefully consider and communicate the risk and duration of withdrawal associated with higher dose and longer-acting opioid antagonists; 3) take-home naloxone kits should include at least two doses of an intramuscular (IM) product containing 0.

View Article and Find Full Text PDF

Perceptions Toward Naloxone Among Patients With Cancer Receiving Opioids.

J Pain Symptom Manage

December 2024

Department of Palliative, Rehabilitation and Integrative Medicine (J.A.D., M.J.K., S.D., R.D., K.T., S.A., A.Z.M., L.A.T., P.B., D.H., J.A., A.H., E.B., A.K.), The University of Texas MD Anderson Cancer, Houston, Texas, USA.

Context: Naloxone nasal spray is recommended for patients with risk factors for opioid overdose. However, cancer patients' perceptions and beliefs regarding naloxone prescriptions and their self-perceived risks for overdose are understudied.

Objective: To determine the proportion of cancer patients at risk for overdose who perceived naloxone as beneficial.

View Article and Find Full Text PDF

Importance: The US Food and Drug Administration approved Narcan, a nasal spray formulation of naloxone, for sale as an over-the-counter (OTC) medication in March 2023. The purpose of OTC approval was to improve naloxone accessibility to reduce opioid overdoses; however, research has not yet evaluated whether naloxone's availability and cost changed since this policy was implemented.

Objective: To evaluate whether the accessibility and cost of naloxone at North Carolina community pharmacies changed after OTC naloxone became available and whether cost and availability varied by pharmacy type and urbanicity.

View Article and Find Full Text PDF

Accessibility of Naloxone in Pharmacies Registered Under the Illinois Standing Order.

West J Emerg Med

July 2024

University of Chicago, Department of Medicine, Section of Infectious Diseases and Global Health, Chicago, Illinois.

Introduction: To expand access to naloxone, the state of Illinois implemented a standing order allowing registered pharmacies to dispense the drug without an individual prescription. To participate under the standing order, pharmacies were required to opt in through a formal registration process. In our study we aimed to evaluate the availability and price of naloxone at registered pharmacies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!